{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T21:52:37Z","timestamp":1791582757181,"version":"4.3.4"},"reference-count":41,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diagnostic Microbiology and Infectious Disease"],"published-print":{"date-parts":[[2027,1]]},"DOI":"10.1016\/j.diagmicrobio.2026.117684","type":"journal-article","created":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T22:48:55Z","timestamp":1790981335000},"page":"117684","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Resistance of Helicobacter pylori to clarithromycin and levofloxacin in patients residing in the VI Region of Chile"],"prefix":"10.1016","volume":"117","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-1266-3608","authenticated-orcid":false,"given":"Laura","family":"Estrella","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-4052-7631","authenticated-orcid":false,"given":"Mauricio","family":"Mosquera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-1682-8895","authenticated-orcid":false,"given":"Juan","family":"Orosco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-4691-116X","authenticated-orcid":false,"given":"Paulina","family":"Meza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-0507-346X","authenticated-orcid":false,"given":"Carmen","family":"Orellana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-4996-7131","authenticated-orcid":false,"given":"Cynthia","family":"Orrego","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9786-2210","authenticated-orcid":false,"given":"Patricio","family":"Gonz\u00e1lez-Hormaz\u00e1bal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-6759-6306","authenticated-orcid":false,"given":"Areli","family":"C\u00e1rdenas-Oyarzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-9080-0461","authenticated-orcid":false,"given":"Ana Mar\u00eda","family":"Salinas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.diagmicrobio.2026.117684_bib0001","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1128\/CMR.00054-05","article-title":"Pathogenesis of Helicobacter pylori infection","volume":"19","author":"Kusters","year":"2006","journal-title":"Clin Microbiol Rev"},{"issue":"1","key":"10.1016\/j.diagmicrobio.2026.117684_bib0002","doi-asserted-by":"crossref","DOI":"10.1186\/s12879-023-08504-5","article-title":"The global prevalence of gastric cancer in Helicobacter pylori-infected individuals: a systematic review and meta-analysis","volume":"23","author":"Shirani","year":"2023","journal-title":"BMC Infect Dis"},{"issue":"1","key":"10.1016\/j.diagmicrobio.2026.117684_bib0003","doi-asserted-by":"crossref","DOI":"10.1186\/s12876-017-0589-6","article-title":"Levofloxacin or clarithromycin-based quadruple regimens: what is the best alternative as first-line treatment for Helicobacter pylori eradication in a country with high resistance rates for both antibiotics?","volume":"17","author":"Branquinho","year":"2017","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.diagmicrobio.2026.117684_bib0004","doi-asserted-by":"crossref","DOI":"10.57187\/smw.2023.40024","article-title":"Clarithromycin-based Helicobacter pylori eradication therapy is not associated with higher treatment failure compared with non-clarithromycin-based regimens in a tertiary referral hospital in Switzerland","volume":"153","author":"Braendli","year":"2023","journal-title":"Swiss Med Wkly"},{"issue":"7","key":"10.1016\/j.diagmicrobio.2026.117684_bib0005","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.gastrohep.2021.11.010","article-title":"Terapias cu\u00e1druples son superiores a terapia triple est\u00e1ndar en primera l\u00ednea de erradicaci\u00f3n de Helicobacter pylori en Chile","volume":"45","author":"Reyes","year":"2022","journal-title":"Gastroenterol Hepatol"},{"issue":"4","key":"10.1016\/j.diagmicrobio.2026.117684_bib0006","doi-asserted-by":"crossref","DOI":"10.3390\/pathogens8040226","article-title":"Prevalence of infection and antibiotic susceptibility of Helicobacter pylori: an evaluation in public and private health systems of Southern Chile","volume":"8","author":"Oporto","year":"2019","journal-title":"Pathogens"},{"issue":"12","key":"10.1016\/j.diagmicrobio.2026.117684_bib0007","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1136\/gutjnl-2022-327745","article-title":"Management of Helicobacter pylori infection: the Maastricht VI\/Florence consensus report","volume":"71","author":"Malfertheiner","year":"2022","journal-title":"Gut"},{"issue":"7","key":"10.1016\/j.diagmicrobio.2026.117684_bib0008","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0160007","article-title":"Surveillance of Levofloxacin Resistance in Helicobacter pylori isolates in Bogot\u00e1-Colombia (2009-2014)","volume":"11","author":"Trespalacios-Rang\u00e9l","year":"2016","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.diagmicrobio.2026.117684_bib0009","doi-asserted-by":"crossref","DOI":"10.1186\/s13104-018-3919-z","article-title":"Highly clarithromycin-resistant Helicobacter pylori infection in asymptomatic children from a rural community of Cajamarca-Peru","volume":"11","author":"Aguilar-Luis","year":"2018","journal-title":"BMC Res Notes"},{"issue":"1","key":"10.1016\/j.diagmicrobio.2026.117684_bib0010","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-56399-7","article-title":"High prevalence of clarithromycin resistance and effect on Helicobacter pylori eradication in a population from Santiago, Chile: cohort study and meta-analysis","volume":"9","author":"Arenas","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.diagmicrobio.2026.117684_bib0011","doi-asserted-by":"crossref","DOI":"10.1590\/s1678-9946201860025","article-title":"The interplay between mutations in cagA, 23S rRNA, gyrA and drug resistance in Helicobacter pylori","volume":"60","author":"Vianna","year":"2018","journal-title":"Rev Inst Med Trop Sao Paulo"},{"issue":"1","key":"10.1016\/j.diagmicrobio.2026.117684_bib0012","doi-asserted-by":"crossref","DOI":"10.1186\/s12876-018-0820-0","article-title":"Prevalence of clarithromycin resistance in Helicobacter pylori in Santiago, Chile, estimated by real-time PCR directly from gastric mucosa","volume":"18","author":"Gonz\u00e1lez-Hormaz\u00e1bal","year":"2018","journal-title":"BMC Gastroenterol"},{"issue":"4","key":"10.1016\/j.diagmicrobio.2026.117684_bib0013","doi-asserted-by":"crossref","first-page":"427","DOI":"10.5152\/tjg.2023.21954","article-title":"Molecular characterization of clarithromycin resistance in Helicobacter pylori strains","volume":"34","author":"\u00d6rsten","year":"2023","journal-title":"Turk J Gastroenterol"},{"key":"10.1016\/j.diagmicrobio.2026.117684_bib0014","doi-asserted-by":"crossref","DOI":"10.1186\/1757-4749-6-27","article-title":"Whole-genome sequencing of clarithromycin resistant Helicobacter pylori characterizes unidentified variants of multidrug resistant efflux pump genes","volume":"6","author":"Iwamoto","year":"2014","journal-title":"Gut Pathog"},{"issue":"4","key":"10.1016\/j.diagmicrobio.2026.117684_bib0015","doi-asserted-by":"crossref","DOI":"10.1111\/hel.13101","article-title":"Antimicrobial resistance of Helicobacter pylori isolated from Latin American children and adolescents (2008-2023): a systematic review","volume":"29","author":"Cabrera","year":"2024","journal-title":"Helicobacter"},{"issue":"4","key":"10.1016\/j.diagmicrobio.2026.117684_bib0016","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.4269\/ajtmh.17-0478","article-title":"Point mutations at gyrA and gyrB genes of levofloxacin-resistant Helicobacter pylori isolates in the esophageal mucosa from a Venezuelan population","volume":"98","author":"L\u00f3pez-Gasca","year":"2018","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.diagmicrobio.2026.117684_bib0017","article-title":"Molecular tools of antibiotic resistance for Helicobacter pylori: an overview in Latin America","volume":"3","author":"Contreras","year":"2024","journal-title":"Front Gastroenterol (Lausanne)"},{"issue":"9","key":"10.1016\/j.diagmicrobio.2026.117684_bib0018","doi-asserted-by":"crossref","first-page":"e609","DOI":"10.1016\/S2214-109X(16)30143-7","article-title":"Global burden of cancers attributable to infections in 2012: a synthetic analysis","volume":"4","author":"Plummer","year":"2016","journal-title":"Lancet Glob Health"},{"issue":"2","key":"10.1016\/j.diagmicrobio.2026.117684_bib0019","doi-asserted-by":"crossref","first-page":"e180","DOI":"10.1016\/S2214-109X(19)30488-7","article-title":"Global burden of cancer attributable to infections in 2018: a worldwide incidence analysis","volume":"8","author":"de Martel","year":"2020","journal-title":"Lancet Glob Health"},{"issue":"4","key":"10.1016\/j.diagmicrobio.2026.117684_bib0020","first-page":"359","article-title":"Usefulness of rapid urease test samples for molecular analysis of clarithromycin resistance in Helicobacter pylori","volume":"50","author":"Baroni","year":"2018","journal-title":"Rev Argent Microbiol"},{"issue":"3","key":"10.1016\/j.diagmicrobio.2026.117684_bib0021","doi-asserted-by":"crossref","DOI":"10.3390\/microorganisms13030583","article-title":"Concordance of Helicobacter pylori detection methods in symptomatic children and adolescents","volume":"13","author":"Cabrera","year":"2025","journal-title":"Microorganisms"},{"issue":"6","key":"10.1016\/j.diagmicrobio.2026.117684_bib0022","doi-asserted-by":"crossref","DOI":"10.3390\/jcm8060858","article-title":"A next-generation sequencing-based approach to identify genetic determinants of antibiotic resistance in Cambodian Helicobacter pylori clinical isolates","volume":"8","author":"Tuan","year":"2019","journal-title":"J Clin Med"},{"key":"10.1016\/j.diagmicrobio.2026.117684_bib0023","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2014.00019","article-title":"Mechanisms of Helicobacter pylori antibiotic resistance and molecular testing","volume":"1","author":"Nishizawa","year":"2014","journal-title":"Front Mol Biosci"},{"issue":"12","key":"10.1016\/j.diagmicrobio.2026.117684_bib0024","doi-asserted-by":"crossref","DOI":"10.3390\/ijms26125628","article-title":"Antibiotic resistance and genetic determinants of Helicobacter pylori in Oman: insights from phenotypic and whole-genome analysis","volume":"26","author":"Al-Hinai","year":"2025","journal-title":"Int J Mol Sci"},{"issue":"11","key":"10.1016\/j.diagmicrobio.2026.117684_bib0025","doi-asserted-by":"crossref","first-page":"3600","DOI":"10.1128\/JCM.00744-09","article-title":"Evaluation of a new test, genotype HelicoDR, for molecular detection of antibiotic resistance in Helicobacter pylori","volume":"47","author":"Cambau","year":"2009","journal-title":"J Clin Microbiol"},{"issue":"4","key":"10.1016\/j.diagmicrobio.2026.117684_bib0026","doi-asserted-by":"crossref","first-page":"730","DOI":"10.4269\/ajtmh.15-0021","article-title":"Helicobacter pylori infection in rural and urban dyspeptic patients from Venezuela","volume":"93","author":"Contreras","year":"2015","journal-title":"Am J Trop Med Hyg"},{"issue":"2","key":"10.1016\/j.diagmicrobio.2026.117684_bib0027","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1590\/S1517-83822011000200005","article-title":"Isolation of Helicobacter pylori in gastric mucosa and susceptibility to five antimicrobial drugs in Southern Chile","volume":"42","author":"Otth","year":"2011","journal-title":"Braz J Microbiol"},{"issue":"4","key":"10.1016\/j.diagmicrobio.2026.117684_bib0028","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1590\/s0004-2803.201900000-72","article-title":"Antibiotic resistance surveillance of HELICOBACTER PYLORI AT the Biob\u00edo region (CHILE) in a decade","volume":"56","author":"Parra-Sep\u00falveda","year":"2019","journal-title":"Arq Gastroenterol"},{"issue":"5","key":"10.1016\/j.diagmicrobio.2026.117684_bib0029","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1111\/j.1523-5378.2007.00506.x","article-title":"Novel genotypes in Helicobacter pylori involving domain V of the 23S rRNA gene","volume":"12","author":"Garrido","year":"2007","journal-title":"Helicobacter"},{"issue":"5","key":"10.1016\/j.diagmicrobio.2026.117684_bib0030","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.arcmed.2021.01.011","article-title":"Prevalence of Helicobacter pylori antimicrobial resistance among Chilean patients","volume":"52","author":"Gonz\u00e1lez-Hormaz\u00e1bal","year":"2021","journal-title":"Arch Med Res"},{"issue":"10","key":"10.1016\/j.diagmicrobio.2026.117684_bib0031","article-title":"Helicobacter pylori primary and secondary genotypic resistance to Clarithromycin and levofloxacin detection in stools: a 4-year scenario in Southern Italy","volume":"9","author":"Losurdo","year":"2020","journal-title":"Antibiotics (Basel)"},{"issue":"4","key":"10.1016\/j.diagmicrobio.2026.117684_bib0032","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.mcna.2011.03.012","article-title":"Review of macrolides (azithromycin, clarithromycin), ketolids (telithromycin) and glycylcyclines (tigecycline)","volume":"95","author":"Zuckerman","year":"2011","journal-title":"Med Clin North Am"},{"issue":"1","key":"10.1016\/j.diagmicrobio.2026.117684_bib0033","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1093\/jac\/42.1.75","article-title":"Gastric mucosal distribution and clinical efficacy of azithromycin in patients with Helicobacter pylori related gastritis","volume":"42","author":"Blandizzi","year":"1998","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.diagmicrobio.2026.117684_bib0034","author":"Herrera Mart\u00ednez"},{"issue":"10","key":"10.1016\/j.diagmicrobio.2026.117684_bib0035","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1136\/gutjnl-2021-324032","article-title":"Helicobacter pylori resistance to antibiotics in Europe in 2018 and its relationship to antibiotic consumption in the community","volume":"70","author":"Megraud","year":"2021","journal-title":"Gut"},{"issue":"1","key":"10.1016\/j.diagmicrobio.2026.117684_bib0036","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1053\/j.gastro.2016.04.006","article-title":"The Toronto Consensus for the treatment of Helicobacter pylori infection in adults","volume":"151","author":"Fallone","year":"2016","journal-title":"Gastroenterology"},{"issue":"9","key":"10.1016\/j.diagmicrobio.2026.117684_bib0037","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.14309\/ajg.0000000000002968","article-title":"ACG Clinical guideline: treatment of Helicobacter pylori infection","volume":"119","author":"Chey","year":"2024","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.diagmicrobio.2026.117684_bib0038","doi-asserted-by":"crossref","DOI":"10.7717\/peerj.11518","article-title":"Current status of Helicobacter pylori resistance to Clarithromycin and Levofloxacin in Malaysia-findings from a molecular based study","volume":"9","author":"Puah","year":"2021","journal-title":"PeerJ"},{"issue":"10","key":"10.1016\/j.diagmicrobio.2026.117684_bib0039","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1136\/gutjnl-2025-335523","article-title":"Helicobacter pylori antibiotic resistance: a global challenge in search of solutions","volume":"74","author":"Schulz","year":"2025","journal-title":"Gut"},{"issue":"10","key":"10.1016\/j.diagmicrobio.2026.117684_bib0040","doi-asserted-by":"crossref","DOI":"10.3390\/antibiotics14101044","article-title":"High prevalence of hefA efflux pump overexpression in isolates of Helicobacter pylori resistant to Clarithromycin","volume":"14","author":"Villegas","year":"2025","journal-title":"Antibiotics"},{"issue":"6","key":"10.1016\/j.diagmicrobio.2026.117684_bib0041","doi-asserted-by":"crossref","DOI":"10.1111\/hel.12447","article-title":"GenoType\u00ae HelicoDR test in comparison with histology and culture for Helicobacter pylori detection and identification of resistance mutations to clarithromycin and fluoroquinolones","volume":"22","author":"Pastukh","year":"2017","journal-title":"Helicobacter"}],"container-title":["Diagnostic Microbiology and Infectious Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889326004359?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889326004359?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T21:08:52Z","timestamp":1791580132000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0732889326004359"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2027,1]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2027,1]]}},"alternative-id":["S0732889326004359"],"URL":"https:\/\/doi.org\/10.1016\/j.diagmicrobio.2026.117684","relation":{},"ISSN":["0732-8893"],"issn-type":[{"value":"0732-8893","type":"print"}],"subject":[],"published":{"date-parts":[[2027,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Resistance of Helicobacter pylori to clarithromycin and levofloxacin in patients residing in the VI Region of Chile","name":"articletitle","label":"Article Title"},{"value":"Diagnostic Microbiology and Infectious Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diagmicrobio.2026.117684","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"117684"}}